Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, and in compliance with the Circular issued by Securities and Exchange Board of India dated July 2, 2025, Abbott India has informed that it enclosed the newspaper advertisement, pertaining to the opening of special window for re-lodgement of the transfer requests of physical shares published in the Business Standard (All Editions) and Loksatta today, Tuesday, July 29, 2025.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1874.30 |
| Dr. Reddys Lab | 1297.00 |
| Cipla | 1317.60 |
| Zydus Lifesciences | 944.10 |
| Lupin | 2262.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: